U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months to 5 years old.
WASHINGTON — U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months to 5 years old while awaiting data on a three-dose course, aiming to clear the way for the shots as soon as late February, a person familiar with the matter told The Associated Press Monday.
The person spoke on the condition of anonymity to discuss sensitive regulatory issues. The person said the decreased effectiveness of the two-dose vaccine was not unexpected given the emergence of the highly transmissible omicron variant of COVID-19. Allowing young kids to be vaccinated with a two-dose shot earlier would ultimately accelerate when they could get the expected stronger protection from a third dose.
Speeding the authorization of pediatric vaccines against COVID-19 has been a priority for more than a year of the Biden administration, which believes them critical to reopening and keeping open schools and day care centers — and for freeing up parents occupied by childcare responsibilities to return to the workforce.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
AP source: US urges Pfizer to apply for under-5 COVID shotsWASHINGTON (AP) — U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for...
Read more »
US Urges Pfizer to Apply for Under-5 COVID Shots: AP SourceU.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months to 5 years old
Read more »
AP source: US urges Pfizer to apply for under-5 COVID shotsRegulators are urging Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months-5 years old while awaiting data on a three-dose course, aiming to clear the way for the shots as soon as late February.
Read more »
US urges Pfizer to apply for COVID vaccine shots for kids under 5U.S. regulators are urging Pfizer to apply for emergency authorization for its COVID-19 vaccine for children 6 months to 5 years old, aiming to clear the way for the shots as soon as late February.
Read more »
U.S. urges Pfizer to apply for COVID shot authorization for kids 5 and underEarly Pfizer data has shown the vaccine is safe and produces an immune response.
Read more »
Pfizer submits data for U.S. authorization of COVID shots for kids under 5 -reportPfizer Inc has begun submitting data to federal regulators as part of the process to win U.S. emergency use authorization (EUA) of its COVID-19 vaccine for children under age 5, Bloomberg reported on Tuesday.
Read more »